Medication reviews for people with developmental disability - a call to action!

Davis, Sharon

doi:10.1002/jppr.1003

Cited by 4 publications

(3 citation statements)

References 3 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…In their narrative literature review, O'Dwyer et al (2015) concluded that there was limited available evidence to suggest the benefit of pharmacist input within the care of people with intellectual disabilities, and therefore, more research was required. This echoed the conclusion of Davis (2014) who concluded there was a lack of published evidence to support pharmacist‐led medication reviews for people with intellectual disabilities living in the community. Flood and Henman (2015) commented that pharmacists may have limited knowledge and experience of people with intellectual disabilities, and therefore, of the challenges this group of patients may face.…”

Section: Discussionmentioning

confidence: 82%

People with intellectual disabilities and their experience of medication: A narrative literature review

MacLeod

MacLure

2020

Research Intellect Disabil

View full text Add to dashboard Cite

Background People with intellectual disabilities are known to have increased medical needs and are prescribed more medication than the general population. Understanding the reality of incorporating medication into their lives would help healthcare professionals provide care in more meaningful and personalised ways. Aim A narrative review of the current literature relating to people with intellectual disabilities and their experience of medication/pharmaceutical care. Method Electronic databases were searched for articles relating to intellectual disabilities and medication administration or pharmaceutical care. Other relevant papers identified from included article reference lists were also identified. A narrative literature was undertaken due to the heterogeneity of the identified papers. Results A total of 29 studies from the literature searches were included alongside other relevant papers. Conclusions The published literature noted some aspects of the medication‐related experiences of people with intellectual disabilities. However, a greater understanding of medication‐related experiences is still required.

show abstract

Section: Discussionmentioning

confidence: 82%

People with intellectual disabilities and their experience of medication: A narrative literature review

MacLeod

MacLure

2020

Research Intellect Disabil

View full text Add to dashboard Cite

show abstract

“…Thus, Burrow and Rimmer (1997) highlighted that poor communication can result in fragmentation of care while others (Brasić et al, 2000; Davis, 2014; Donnelly, 2013; Shaw and Hodson, 2016) identified the need for medication reviews to be undertaken at specified intervals. Many authors, though, recommended the provision of education and training to staff (Burrow and Rimmer, 1997; Dam et al, 2015; Davis, 2014; Davis et al, 2015; Deepak et al, 2012; Erickson et al, 2016; Halder et al, 2012; Heslop et al, 2005; Joos et al, 2015, 2016a), informal carers (Burrow and Rimmer, 1997; Doyle and Cronin, 2017; Erickson et al, 2016; Halder et al, 2012; Heslop et al, 2005) and people with an intellectual disability (Buckley, 2013; Burrow and Rimmer, 1997; Davis et al, 2016; Donnelly, 2013; Erickson et al, 2016; Heslop et al, 2005; Rasaratnam et al, 2004), with Rasaratnam et al (2004) noting that lack of the same can lead to uninformed negative perspectives on medications among people with an intellectual disability and their carers. The administrative processes that were identified are undertaking medication review (Deb et al, 2006; DHHS, 2017; HIQA, 2015; NIHCE, 2014); recording keeping (DHHS, 2017; DSHS, 2017; HIQA, 2015; NFVB, 2009; NIHCE, 2014); communicating (DHHS, 2017); managing medication incidents/errors (DHHS, 2017; HIQA, 2015; NFVB, 2009; NIHCE, 2014); safeguarding and monitoring for adverse reactions (Deb et al, 2006; DHHS, 2017; NFVB, 2009; NIHCE, 2014…”

Section: Resultsmentioning

confidence: 99%

Medication management in intellectual disability settings: A systematic review

Sheerin

Eustace‐Cook

Wuytack

et al. 2019

J Intellect Disabil

View full text Add to dashboard Cite

There is a high level of medication usage among people with intellectual disability due to the presence of significant morbidity and co-morbidities. This review sought to explore medication management and administration in intellectual disability settings, identifying frameworks for practice, analysing whether collaborative practice led to better outcomes, identifying key processes associated with practice, locating tools to support practice and describing metrics for outcome measurement. A systematic review was conducted with analysis of 64 sources which remained following screening and appraisal. Limited evidence was identified with some insight into the processes underpinning medication management and administration. No assessment tools were found, but two potential outcome measures, adherence and errors, were noted. The paucity of guidelines and frameworks is concerning as this is a complex area of practice. There is a need for further practice development and research to be undertaken that takes note of the unique issues that can present in intellectual disability settings.

show abstract

“…It is possible that clinical pharmacists have not documented the services they provide. While examples of innovative practice undoubtedly exist, the lack of practice-based research to inform service delivery remains a concern [8]. This is particularly true given the high rates of psychotropic use, frequent off-label prescribing, and minimal evidence for medication efficacy [9,10].…”

mentioning

confidence: 99%